GM&C Life Sciences Fund

GM&C Life Sciences Fund

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United Kingdom, Alderley Edge


GM&C Life Sciences Fund was established in 2015, and is a well known VC. The main office of this VC is situated in Alderley Edge. The fund is located in United Kingdom, Europe.

AMR Centre, SurgaColl, Proveca are amongst the various portfolio companies of this fund. We can highlight the most popular investment areas for this fund, such as Medical, Therapeutics. In addition, there are 8 more industries where it has achieved success. The average start-up age at the time of investment by this fund is 6-10. The country of its foundation and the country of the most frequent investments for the fund coincides - United Kingdom. In addition to this location, the fund participated in 1 other location. The fund has no a preferred number of founders for start-ups that it invests in.

In terms of the fund's performance, this VC has 53 percentage points more exits when compared to other organizations. The fund typically enters into 7-12 deals annually. This fund was the most active in 2016. Additionally, in 2019 the fund was active. The most common rounds for this fund are in the range of 1 - 5 millions dollars.

The fund usually invests in rounds together with 2-3 others. Along with GM&C Life Sciences Fund, start-ups are often financed by Wren Capital, The North West Fund, SBRI Healthcare as well as 3 other investors. The fund often co-invests with UK Innovation & Science Seed Fund, Deepbridge Capital, Catapult Ventures. The investors in the following rounds are usually EASME - EU Executive Agency for SMEs, 24 Haymarket, SciTech.

Year Founded


Fund Activity


Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

3.7% of cases

Funds Investing in Previous

Wren Capital, The North West Fund, SBRI Healthcare

Funds Investing in Following

EASME - EU Executive Agency for SMEs, 24 Haymarket, SciTech

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: